| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| USD | 675.000 | 10 | Mar-31 | Sr. Unsecured | Baa2 | BBB- | BBB | Fixed | Tsy | T+135 a | T+115 a | 110 | 2.70% | - | 99.89700 |
| USD | 675.000 | 30 | Mar-51 | Sr. Unsecured | Baa2 | BBB- | BBB | Fixed | Tsy | T+170 a | T+150 a | 145 | 3.75% | - | 99.52000 |
Tranche Comments
10 yr: Book size: 2400; Registration: Registered; Comments: US$675m 2.70% cpn 10-year(3/15/31) at 99.897, yld 2.712%. Spread: T+110bp. MWC T+20bp. CoC: 101%;
30 yr: Book size: 2600; Registration: Registered; Comments: US$675m 3.75% cpn 30-year(3/15/51) at 99.52, yld 3.777%. Spread: T+145bp. MWC T+25bp. CoC: 101%;
Deal Comments
Active Bookrunners: JPM(B&D), BAM, CTI. Passive Bookrunner: PNC
Guarantor(s)
STERIS plc, STERIS Ltd and STERIS Corp
Use of Proceeds
Refinancing and general corporate expenses and working capital needs